239 related articles for article (PubMed ID: 36150479)
1. Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data.
Ye L; Ngan DK; Xu T; Liu Z; Zhao J; Sakamuru S; Zhang L; Zhao T; Xia M; Simeonov A; Huang R
Toxicol Appl Pharmacol; 2022 Nov; 454():116250. PubMed ID: 36150479
[TBL] [Abstract][Full Text] [Related]
2. Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).
Minerali E; Foil DH; Zorn KM; Lane TR; Ekins S
Mol Pharm; 2020 Jul; 17(7):2628-2637. PubMed ID: 32422053
[TBL] [Abstract][Full Text] [Related]
3. Predictive Models for Human Organ Toxicity Based on
Xu T; Ngan DK; Ye L; Xia M; Xie HQ; Zhao B; Simeonov A; Huang R
Chem Res Toxicol; 2020 Mar; 33(3):731-741. PubMed ID: 32077278
[TBL] [Abstract][Full Text] [Related]
4. Integrating adverse outcome pathways (AOPs) and high throughput in vitro assays for better risk evaluations, a study with drug-induced liver injury (DILI).
Khadka KK; Chen M; Liu Z; Tong W; Wang D
ALTEX; 2020; 37(2):187-196. PubMed ID: 31707421
[TBL] [Abstract][Full Text] [Related]
5. A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.
Chen M; Tung CW; Shi Q; Guo L; Shi L; Fang H; Borlak J; Tong W
Arch Toxicol; 2014 Jul; 88(7):1439-49. PubMed ID: 24958025
[TBL] [Abstract][Full Text] [Related]
6. Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints.
Kim E; Nam H
BMC Bioinformatics; 2017 May; 18(Suppl 7):227. PubMed ID: 28617228
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
[TBL] [Abstract][Full Text] [Related]
8. A human liver organoid screening platform for DILI risk prediction.
Zhang CJ; Meyer SR; O'Meara MJ; Huang S; Capeling MM; Ferrer-Torres D; Childs CJ; Spence JR; Fontana RJ; Sexton JZ
J Hepatol; 2023 May; 78(5):998-1006. PubMed ID: 36738840
[TBL] [Abstract][Full Text] [Related]
9. AI/ML Models to Predict the Severity of Drug-Induced Liver Injury for Small Molecules.
Rao M; Nassiri V; Alhambra C; Snoeys J; Van Goethem F; Irrechukwu O; Aleo MD; Geys H; Mitra K; Will Y
Chem Res Toxicol; 2023 Jul; 36(7):1129-1139. PubMed ID: 37294641
[TBL] [Abstract][Full Text] [Related]
10. Early Drug-Induced Liver Injury Risk Screening: "Free," as Good as It Gets.
Martin MT; Koza-Taylor P; Di L; Watt ED; Keefer C; Smaltz D; Cook J; Jackson JP
Toxicol Sci; 2022 Jul; 188(2):208-218. PubMed ID: 35639956
[TBL] [Abstract][Full Text] [Related]
11. A high content screening assay to predict human drug-induced liver injury during drug discovery.
Persson M; Løye AF; Mow T; Hornberg JJ
J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
[TBL] [Abstract][Full Text] [Related]
12. Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure.
Liu A; Walter M; Wright P; Bartosik A; Dolciami D; Elbasir A; Yang H; Bender A
Biol Direct; 2021 Jan; 16(1):6. PubMed ID: 33461600
[TBL] [Abstract][Full Text] [Related]
13. Hybrid in silico models for drug-induced liver injury using chemical descriptors and in vitro cell-imaging information.
Zhu XW; Sedykh A; Liu SS
J Appl Toxicol; 2014 Mar; 34(3):281-8. PubMed ID: 23640866
[TBL] [Abstract][Full Text] [Related]
14. Development of binary classification models for assessment of drug-induced liver injury in humans using a large set of FDA-approved drugs.
Zhang H; Zhang HR; Hu ML; Qi HZ
J Pharmacol Toxicol Methods; 2022; 116():107185. PubMed ID: 35623583
[TBL] [Abstract][Full Text] [Related]
15. Predicting drug-induced liver injury in human with Naïve Bayes classifier approach.
Zhang H; Ding L; Zou Y; Hu SQ; Huang HG; Kong WB; Zhang J
J Comput Aided Mol Des; 2016 Oct; 30(10):889-898. PubMed ID: 27640149
[TBL] [Abstract][Full Text] [Related]
16. Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations.
Albrecht W; Kappenberg F; Brecklinghaus T; Stoeber R; Marchan R; Zhang M; Ebbert K; Kirschner H; Grinberg M; Leist M; Moritz W; Cadenas C; Ghallab A; Reinders J; Vartak N; van Thriel C; Golka K; Tolosa L; Castell JV; Damm G; Seehofer D; Lampen A; Braeuning A; Buhrke T; Behr AC; Oberemm A; Gu X; Kittana N; van de Water B; Kreiling R; Fayyaz S; van Aerts L; Smedsrød B; Ellinger-Ziegelbauer H; Steger-Hartmann T; Gundert-Remy U; Zeigerer A; Ullrich A; Runge D; Lee SML; Schiergens TS; Kuepfer L; Aguayo-Orozco A; Sachinidis A; Edlund K; Gardner I; Rahnenführer J; Hengstler JG
Arch Toxicol; 2019 Jun; 93(6):1609-1637. PubMed ID: 31250071
[TBL] [Abstract][Full Text] [Related]
17. Bioactivity Signatures of Drugs vs. Environmental Chemicals Revealed by Tox21 High-Throughput Screening Assays.
Ngan DK; Ye L; Wu L; Xia M; Rossoshek A; Simeonov A; Huang R
Front Big Data; 2019; 2():50. PubMed ID: 33693373
[TBL] [Abstract][Full Text] [Related]
18. Predicting Drug-Induced Liver Injury with Bayesian Machine Learning.
Williams DP; Lazic SE; Foster AJ; Semenova E; Morgan P
Chem Res Toxicol; 2020 Jan; 33(1):239-248. PubMed ID: 31535850
[TBL] [Abstract][Full Text] [Related]
19. Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles.
Huang R; Xia M; Sakamuru S; Zhao J; Lynch C; Zhao T; Zhu H; Austin CP; Simeonov A
Sci Rep; 2018 Feb; 8(1):3783. PubMed ID: 29491351
[TBL] [Abstract][Full Text] [Related]
20. Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints.
Liu X; Zheng D; Zhong Y; Xia Z; Luo H; Weng Z
Biomed Res Int; 2020; 2020():4795140. PubMed ID: 32509859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
